Ruth Murray

TL;DR: This study is the first to describe severe asthma characteristics of a large cohort of patients included in multiple severe asthma registries, and to identify country differences.

TL;DR: The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status.

TL;DR: An overview of the methods used in MASK and the key results obtained to date include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life and the potential usefulness of MASK will be further explored.

TL;DR: This observational study using a very simple assessment tool (VAS) on a mobile phone had the potential to answer questions previously thought infeasible on medication use, disease control, and work productivity in patients with AR.

TL;DR: MP29-02 provided faster and more complete symptom control than first-line therapies and may be considered the drug of choice for moderate-to-severe AR, and defines a new standard for assessing relevance in AR.